Skip to main content
. 2020 Mar 31;27(1):502–518. doi: 10.1080/10717544.2020.1745328

Figure 6.

Figure 6.

Transport across the BBB of novel biomimetic nanosystems. (A) Schematic diagram of in vitro BBB model. (B) FCM analysis of HT22 cells treated with various Cou6-tagged formulations after crossing the BBB-HT22 cells co-culture in vitro model. (C) In vivo brain-targeting ability. Biodistribution of DIR contained in various formulations determined by IVIS Lumina II.